Pharmaceutical companies play a central role in the digital revolution of healthcare. And the revolution is well underway. In 2014, investments topped $7.0 billion, compared to last year’s $3.0 billion.
In order to stay well ahead, Pharma and Healthcare companies sought to learn new trends and implications of digital solutions.
These digital solutions and innovations will need strict quality management implementations. Life-and-death consequences require that these systems must relay data accurately, gather data precisely, process and transfer data with integrity and efficiently across other systems. Furthermore, UX functionalities should be intuitive and friendly to the general public in order reach out to more accepting users.
Here at CHEQ, we use risk-based analysis to create test designs that aim to capture the most important testing requirements of these systems, with the goal of ensuring public safety. We use FMEA (Failure Mode and Effects Analysis) to help developers focus on the more important components of the software system.